Claims Matrix Analysis
Claims Matrix analysis helps Regulatory Affairs Teams and Quality Assurance Leadership evaluate claim substantiation maturity, evidence traceability strength, promotional-risk exposure, and labeling review readiness before external claims review decisions.
What Regulatory Teams Can Decide From the Analysis
Is claim scope clearly defined?
Identify whether the Claims Matrix defines claim categories, intended audiences, use boundaries, review context, and responsible owners, so teams can confirm governance scope before claims approval.
Where could promotional risk appear?
Spot missing substantiation, weak evidence links, conflicting benefit language, outdated references, or traceability gaps, before they create approval risk, audit exposure, or submission delay.
Can teams make a more defensible decision?
Evaluate whether the Claims Matrix provides enough clinical evidence, supporting detail, and source references, for regulatory, clinical, and marketing teams to revise with confidence.
How Teams Use This Analysis
Regulatory and quality teams use Claims Matrix analysis to review claims inventories more consistently, catch promotional-risk exposure earlier, and turn claim language into decisions about substantiation planning and labeling alignment.
Labeling Compliance Pre-Review
Surfaces missing risk disclosures, unsupported superiority language, and unclear use limitations, giving Regulatory Affairs Teams earlier visibility into labeling risk before the Claims Matrix reaches approval.
AI/ML Device Regulatory Signal Analysis
Checks whether AI performance evidence and software references hold together, reducing the chance that teams rely on unsupported claims.
Regulatory Pathway Mapping
Turns scattered claim language into structured findings, helping regulatory teams prioritize submission strategy, evidence gaps, and escalation paths.
Evidence Reusability Check
Connects evidence maturity to substantiation planning, giving teams a clearer basis for early cross-functional submission and commercialization decisions.
Clinical Claims Review
Maps clinical benefit claims and outcome assertions into a clearer review position, helping Clinical & Medical Affairs Teams understand evidence sufficiency before labeling review.
Information Gap Analysis
Organizes open substantiation questions and reviewer notes into a practical follow-up path, so unresolved issues can be addressed before they become approval blockers.
Key Claims Matrix Insights to Look For
Automatan organizes Claims Matrix evaluation into structured insights that help teams judge substantiation coverage, regulatory alignment, labeling readiness, and the quality of the evidence behind claims-governance decisions.
Document Name
Claims-matrix title is captured to maintain review traceability and avoid version confusion across all claims-governance cycles.
Document Type
The document-type classification provides a consistent anchor for insights, ensuring the analysis stays linked to the correct claims-governance artifact.
Device Name
A structured summary of product identity, healthcare context, and commercialization role gives teams immediate context without scope confusion.
Device Description
Extracted functional description signals distinguish explicit commitments from implied intent, helping teams focus substantiation planning where it matters most.
Claims Matrix Overview
Classification of formal versus informal structure clarifies which governance lens applies and directs early substantiation evidence collection.
Claim Source Origin
Flags marketing-led ownership to highlight elevated promotional scrutiny and prioritize review efforts.
Substantiation Status
Determines substantiated or unsupported status to guide evidence assignment and review-control expectations.
Evidence Type
Clinical versus nonclinical evidence designation informs the correct substantiation framework and review rule.
Device Purpose
Primary, supportive, or decision-support purpose signals shape intended-use classification and monitoring priorities.
Intended Use Signals
Interaction with clinical workflow or care settings is identified, ensuring software functions or device features are properly scoped.
Device Class
Low-risk, moderate-risk, or high-scrutiny signals provide clarity on classification scope and regulatory relevance.
Comparative Language
Automated extraction of comparison context, such as competitor references or standard-of-care benchmarks, informs promotional risk and evidence requirements.
Superiority & Equivalence Claims
Directional superiority and equivalence signals offer early insight for comparative substantiation planning.
Economic & Cost-Benefit Claims
Workflow-efficiency claims and reimbursement language anchor value reasoning and support commercial-risk mapping.
Clinical Outcome
Identifies clinician, patient, or care-team beneficiaries to guide outcome framing, evidence priorities, and review focus.
Safety Language
Required safety-review expertise signals inform risk planning and evidence study design.
Performance Metrics
Measurement context, including sensitivity, specificity, accuracy, or precision, ensures performance-risk alignment with actual use conditions.
Claims & Clinical Assertions
Automatan compiles clinical, performance, comparative, and AI-related claims to highlight potential evidence and promotional focus areas.
Regulatory Impact of Claims
Mapping claim-risk implications guides prioritization of substantiation documentation and ensures review requirements are addressed early.
Device Characteristics
Technical and operational traits, including connectivity, automation, and workflow fit, affect regulatory planning and validation.
Who Uses This Analysis
Claims Matrix review pulls in several stakeholders at once. Each group needs a different cut of the same document, focused on the regulatory, quality, clinical, commercial, and governance questions closest to its mandate.
Regulatory Affairs Teams
Reads Claims Matrix for substantiation maturity, using the analysis to decide whether external claims review can proceed.
Quality Assurance Leadership
Reviews traceability coverage, helping the team identify governance gaps before approval workflows advance.
Marketing & Commercial Teams
Checks comparative language and supporting references, making sure the document can support promotional review.
Clinical & Medical Affairs Teams
Uses the analysis to compare clinical benefit claims against cited evidence, giving stakeholders a clearer basis for revision decisions.
Startup Founders & Product Leadership
Assesses the overall claims posture to determine whether the claims package supports commercialization planning.
How Claims Matrix Analysis Connects to Your Labeling Review Workflow
Automatan works inside the tools regulatory teams already use. Claims Matrices and supporting files can be imported from common document sources and turned into structured claims-governance intelligence without rebuilding the review process.
Google Drive
Import documents directly from Google Drive so Automatan can extract claim signals and substantiation indicators from files already stored by the team.
Add AI Integration
Google Docs
Analyze Claims Matrices stored in Google Docs without moving files, enabling seamless extraction of regulatory insights within the existing workspace.
Add AI Integration
OneDrive
Access documents from OneDrive so teams in regulated environments can capture promotional-risk signals directly from their repository.
Add AI Integration
Dropbox
Pull claims inventories from Dropbox to turn embedded evidence references, comparative language, and approval metadata into structured review intelligence inside Automatan.
Add AI IntegrationAnalyze Claims Matrices With Clearer Substantiation Evidence
Regulatory Affairs Teams and Quality Assurance Leadership need more than claims. Automatan helps teams analyze Claims Matrices for substantiation maturity, labeling readiness, and follow-up actions, so every review leads to clearer claims-governance decisions.